July 16 Open House Highlights Expanded Sterile Filling Contract Manufacturing Capabilities for Small and Large Molecules

Newly-cleared technology is a game changer for the diagnosis of an often debilitating disease.

Breakthrough bioconvergence platform detects inflammatory events prior to symptoms, partnering with Altesa Biosciences to transform care

Sensifai emerges from stealth with a landmark peer-reviewed study in The Lancet Digital Health, validating its world-first AI platform to detect inflammatory events before symptoms, redefining how and when care begins.

Smile Digital Health is the first vendor to be validated by NCQA as qualified to run digital HEDIS measures with their dQM Solution.

FEATURED WORKSHOP - Introducing Empowerment-Based Integrated Treatment (EBiT)

ReadyRx - GLP-1 introduces a physician-guided support framework offering structured 3-, 6-, and 12-month access to compounded GLP-1 protocols, combining clinical oversight with habit-forming wellness strategies for sustainable weight management.

2025 Longevity Programs From ReadyRx Integrate Clinical Data, Primate Research, and TAME Trial Insights to Deliver Personalized Metformin Therapy via Secure Telehealth Platform

Golden Puppies, a Louisiana-based Golden Retriever and Goldendoodle breeder, announces donation of a Goldendoodle puppy to American Red Cross volunteer

The new 4-in-1 cardiovascular screening package helps adults over 40 detect stroke and heart attack risks early through non-invasive, physician-reviewed tests aligned with updated AHA prevention guidelines.

Designed for real-life mobility, the Toyota Sienna Hybrid FlexMaxx™ offers families and individuals a quiet, fuel-efficient and adaptable solution for everyday travel.

Initial Collaboration Launches at Yukon, OK Site

Wattbike acquisition is the latest milestone in transformational strategy and the Sportstech acquisition is on track to close in the third quarter

TRNR confirms guidance of more than $75 million in pro forma 2025 revenue and profitability in fourth quarter

TRNR's $55 million Digital Asset Treasury is actively purchasing $FET cryptocurrency

Imagene AI delivers a living intelligence engine for adaptive, insight-driven precision medicine.

Built by industry veterans, the iProElite system offers multi-modality flexibility, real-world support, and clinical protocols designed to grow with your practice.

The GOAT Collection features game-worn memorabilia from Michael Jordan, LeBron James, and Kobe Bryant; The Grail Collection to follow with high value assets from sports history's most iconic legends.

While Chinese cartels built a marijuana empire across at least six states, MMJ-a Rhode Island-based company with FDA orphan drug status-was left to rot in a bureaucratic black hole engineered by DEA Diversion officials Matthew Strait, Thomas Prevoznik, Anne Milgram and Aarathi Haig.

Clinically-informed routines backed by garlic, hawthorn berry, and hibiscus highlight Heart Freedom's botanical approach to sustained blood pressure support, circulation enhancement, and heart health integration in 2025.

The 2025 launch of the Herz P1 Smart Ring introduces a sleek, all-weather wearable that tracks sleep, stress, heart rate variability, blood oxygen, and temperature - delivering continuous health insights through a durable, low-maintenance, app-connected device.

A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), and glucagon (GCG) receptors

Company will also develop a subcutaneous version, PN-477sc, as a once-weekly injection

IND-enabling studies underway, with Phase I study initiation expected in 2Q26

Webcast and conference call to be held today at 4:30 pm ET

OIC International brings modular trauma systems to underserved global markets, advancing surgical care through innovation, accessibility, and regional collaboration.

Partners With ASE to Scale AI Nose Deployment and Set New Standard in Intelligent Sensing

Achieves Strategic Inflection Point in 1H 2025 with Partnerships and Operational Breakthroughs

Oral therapy designed to minimize CNS side effects shows dual activity in weight loss and smoking cessation models without muscle loss

mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in adults aged 50 years and older

Retirements Reported in DEA's DIVERSION as "DOGE CASUALTIES".

Fueled by screen fatigue, blue light exposure, and age-related eye concerns, Visiultra's science-backed formula featuring lutein, zeaxanthin, and astaxanthin is gaining traction among adults seeking daily vision support and long-term ocular clarity in 2025.

Survey findings underscore significant improvements in medical practice denial management, patient engagement, and operational efficiency driven by advanced technologies.

Relationship Broadens Scope to Key ASE and SPIL Facilities with Multi-Phase Deployment

Milestone Positions ASEH and Ainos as First-Mover in AI-Powered Scent Intelligence for the Semiconductor Industry

Earn Continuing Education credits and learn about the complex interplay between alcohol use disorder (AUD) and common co-occurring psychiatric conditions, including bipolar disorder, major depressive disorder, and generalized anxiety disorder.

New Cardiovascular Formula Lipidene Gains Attention for Natural Cholesterol and Artery Health Support, Backed by Botanical Science and Clinical Ingredient Data

How ProXental's essential oil and antioxidant dental gel supports gum appearance and oral freshness, with science-backed insights, ingredient analysis, daily usage plans, and long-term wellness integration strategies for 2025.

New Edition Offers Actionable Insights for MedTech Companies and More Targeting Hospital Infrastructure Growth in the Region

Strategic decision positions Jaguar to diversify treasury holdings with a long-term digital store of value

Webcast and conference call to be held on Monday, June 30th at 4:30 pm ET, dial in information below

Cardio Shield, developed by Apollo Research, emerges as the leading cardiovascular supplement of 2025 with a clinically inspired, natural formula designed to support blood pressure, circulation, and heart function - backed by real user results, scientific validation, and a 180-day risk-free guarantee.

Clinically Researched Supplement Targets Parathyroid Hormone to Support Balance, Ease Vertigo Symptoms, and Promote Inner Ear Health Naturally in 2025

A collection of articles, case reports and industry news for dental professionals.

Medical equipment provider delivers on-demand solutions for patients with high BMIs

Lon G. von Hurwitz, who will serve as chief strategist and senior advisor, brings 30-plus years of leadership experience in healthcare innovation, marketing, and public health initiatives and will guide efforts to bring the smart medication delivery technology to market in early 2026.